Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

NK cells in the CD19- B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors.

King AM, Keating P, Prabhu A, Blomberg BB, Riley RL.

Mech Ageing Dev. 2009 Jun;130(6):384-92. doi: 10.1016/j.mad.2009.03.002. Epub 2009 Mar 24.

2.

Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage.

Alter-Wolf S, Blomberg BB, Riley RL.

Mech Ageing Dev. 2009 Jun;130(6):401-8. doi: 10.1016/j.mad.2009.04.001. Epub 2009 Apr 9.

3.

Calmodulin inhibition of E2A stops expression of surrogate light chains of the pre-B-cell receptor and CD19.

Hauser J, Wallenius A, Sveshnikova N, Saarikettu J, Grundström T.

Mol Immunol. 2010 Feb;47(5):1031-8. doi: 10.1016/j.molimm.2009.11.015. Epub 2009 Dec 21.

PMID:
20022378
4.
5.

The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins.

Sherwood EM, Xu W, King AM, Blomberg BB, Riley RL.

Mech Ageing Dev. 2000 Sep 1;118(1-2):45-59.

PMID:
10989124
7.

A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors.

Rolink A, ten Boekel E, Melchers F, Fearon DT, Krop I, Andersson J.

J Exp Med. 1996 Jan 1;183(1):187-94.

8.
9.
10.

Broad feedback inhibition of pre-B-cell receptor signaling components.

Hauser J, Verma-Gaur J, Grundström T.

Mol Immunol. 2013 Jul;54(3-4):247-53. doi: 10.1016/j.molimm.2012.12.002. Epub 2013 Jan 12.

PMID:
23318223
11.

Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice.

Frasca D, Nguyen D, Riley RL, Blomberg BB.

J Immunol. 2003 Jan 15;170(2):719-26.

12.

In aged mice, low surrogate light chain promotes pro-B-cell apoptotic resistance, compromises the PreBCR checkpoint, and favors generation of autoreactive, phosphorylcholine-specific B cells.

Ratliff M, Alter S, McAvoy K, Frasca D, Wright JA, Zinkel SS, Khan WN, Blomberg BB, Riley RL.

Aging Cell. 2015 Jun;14(3):382-90. doi: 10.1111/acel.12302. Epub 2015 Feb 27.

13.

Decreased E47 in senescent B cell precursors is stage specific and regulated posttranslationally by protein turnover.

Van der Put E, Frasca D, King AM, Blomberg BB, Riley RL.

J Immunol. 2004 Jul 15;173(2):818-27.

15.

Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent.

Ikawa T, Kawamoto H, Wright LY, Murre C.

Immunity. 2004 Mar;20(3):349-60.

16.

A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.

Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, Sigvardsson M, Hagman J, Espinoza CA, Dutkowski J, Ideker T, Glass CK, Murre C.

Nat Immunol. 2010 Jul;11(7):635-43. doi: 10.1038/ni.1891. Epub 2010 Jun 13.

17.
18.

B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells.

Mansson R, Zandi S, Anderson K, Martensson IL, Jacobsen SE, Bryder D, Sigvardsson M.

Blood. 2008 Aug 15;112(4):1048-55. doi: 10.1182/blood-2007-11-125385. Epub 2008 May 21.

19.

IL-15 inhibits pre-B cell proliferation by selectively expanding Mac-1+B220+ NK cells.

Nakajima S, Hida S, Taki S.

Biochem Biophys Res Commun. 2008 May 16;369(4):1139-43. doi: 10.1016/j.bbrc.2008.03.004. Epub 2008 Mar 11.

PMID:
18339305

Supplemental Content

Support Center